So you think this is a low-risk/high-reward stock valued at 1...something? I agree on potential high-reward but any entrepreneurial venture is fraught with risk. There are many factors out of Management's control (e.g. delivery delays).
On an entirely different topic,I think this morning's PR was done so that Management would avoid any negative surprises in the eyes of the market and shareholders down the road if there were delays on their prior projections. I think Management is trying their best to communicate what they can transparently.
However, regarding toxicology, I think they know their production capacity and in turn how long it will take to produce the necessary quanitites, neither of which were conveyed in the the message. I think the choice not to communicate 'when' was made intentionally. From here, hoping for sooner than later. A couple of 'nice' surprises in between could add to a boost in SP when toxicology commencent, progress and results are eventually released.
I am not negative on this company or management. I am invested...not flipping a few shares for lunch money as people have been accused of doing. However I find no fault with anyone who can build a position trading this stock. Any shares purchased this spring and sold into last weeks trading range yielded a healthy return.
News 
Market Data 
Discover 
AI
